THOR - Tübingen Choroideremia Gene Therapy Trial
NCT02671539
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Choroideremia
Interventions
GENETIC:
rAAV2.REP1
Sponsor
STZ eyetrial
Collaborators
[object Object]